Wegovy symptoms in the first week: what most people get wrong

Nausea is the most frequently reported symptom at the 0.25 mg starting dose, but it is typically mild-to-moderate and often settles within days.
The first-week dose of semaglutide (0.25 mg) is a tolerability step: its primary job is to let your system adjust, not to produce significant weight change.
GI symptoms tend to be most intense in the 24–48 hours after injection and are often largely resolved by the end of the first week for most starters.
Staying well-hydrated and eating smaller, lower-fat meals in the first week is widely reported to reduce symptom intensity.

Most people starting Wegovy expect to feel rough for the entire first week. That fear is understandable, but it is not quite what the evidence shows. The most common symptoms — nausea, mild fatigue, and some digestive change — are real, but they tend to peak in the first two to four days after the initial injection and ease considerably for many people before the week is out. These are prescription-only medicines, and a clinician will assess your full health picture before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the first week of Wegovy actually looks like, hour by hour

The myth: a week of constant nausea from the very first dose

The most persistent misconception around starting Wegovy is that the first week is a continuous battle with nausea. Search forums and you will find alarming accounts, but you will also find plenty of people who felt little beyond a slightly unsettled stomach for a day or two. Both experiences are real; neither is universal.

What the clinical picture actually shows is more nuanced. The 0.25 mg starting dose of semaglutide is genuinely low. It was chosen precisely because higher doses produced more GI side effects in early trials, and this introductory step brings most people through the first month with manageable rather than debilitating symptoms. Wegovy's licensed schedule keeps you at 0.25 mg for four weeks before any increase, which means your body has time to adapt before the dose climbs.

The NHS medicines page for semaglutide lists the common side effects honestly: nausea, vomiting, diarrhoea, constipation, headache, fatigue, dizziness, and injection-site reactions. "Common" in medicine means affecting between 1 in 10 and 1 in 100 people, so not everyone encounters even the most frequent ones. Nausea sits at the top of the list, but most people who report it describe it as a background queasiness rather than the incapacitating kind.

If you are planning your first week, a practical look at the first Wegovy week covers what to eat, when to inject, and what to have to hand.

What actually tends to happen: a day-by-day pattern

The timing of symptoms follows semaglutide's pharmacology fairly predictably. The drug reaches peak plasma concentration roughly 24–72 hours after each injection. For most people, any nausea arrives in that window and then recedes. By day four or five of the first week, many starters feel broadly back to normal, perhaps with a noticeably reduced appetite, which is the intended effect beginning to establish itself.

Fatigue and headache, where they occur, often appear on day one or two and resolve quickly. Constipation, if it develops, tends to build more slowly and may not be obvious in week one at all. Diarrhoea is less common at the starting dose than at higher maintenance doses. Injection-site redness or mild stinging at the site on the abdomen, thigh, or upper arm is common immediately after the pen is used and usually fades within a couple of hours.

For people curious about how quickly the medicine begins acting on weight, first-week results on Wegovy addresses what to realistically expect in terms of the scales, which is usually not the right thing to watch in week one. Understanding how long Wegovy takes to work puts the first seven days in its proper context within the full titration journey.

One practical note: the pen itself arrives in a plain, unmarked box via DPD tracked delivery, so there is no waiting by the door anxiously, you will know exactly when it is coming. Keep it in the fridge until injection day.

Symptoms that need prompt medical attention

The vast majority of first-week symptoms are uncomfortable rather than dangerous. A few, though, need a same-day call to your prescriber or GP, or emergency care if severe.

Severe, persistent abdominal pain that radiates to the back (with or without vomiting) should be assessed urgently. Pancreatitis is a known but infrequent risk with GLP-1 medicines; the MHRA's Yellow Card scheme invites patients to report suspected side effects, and in January 2026 the MHRA issued a specific Drug Safety Update reinforcing the need to seek urgent care for this symptom pattern. Signs of a serious allergic reaction (facial swelling, difficulty breathing, severe skin rash) also require emergency attention.

Dehydration from vomiting or diarrhoea is worth monitoring. If you cannot keep fluids down for more than a day, contact a clinician. Symptoms lasting well beyond the first week, or worsening rather than settling after a dose, are also a prompt to get in touch rather than push through. How long Wegovy symptoms typically last has more on the expected timeline and when to be concerned.

On the question of cost (if you are still weighing up whether private treatment makes sense) Wegovy's UK pricing sets out what a legitimate private prescription typically includes and what to watch for with very low-priced offers online.

Practical steps that genuinely help in week one

Small meals, eaten slowly, make a real difference. Rich, fatty or heavily spiced food amplifies nausea in many people using semaglutide, so keeping meals plain and moderate in the first few days is worth the effort. Eating before the injection rather than straight after can also reduce the severity of GI symptoms for some.

Hydration matters. Nausea suppresses thirst, which can tip people into mild dehydration and worsen headaches and fatigue. Sipping water steadily throughout the day (rather than large amounts at once) tends to work better alongside a slowed gastric-emptying effect.

Timing the injection in the evening means that for many people the worst of any nausea coincides with sleep, rather than a working day. There is no clinical requirement to inject in the evening, but it is a practical option worth considering in week one. Your prescriber is the right person to ask about adjustments specific to your routine; early experiences on semaglutide also covers coping strategies in more detail.

If starting treatment is something you are considering, speak to our prescribers to have your eligibility reviewed properly, a real clinician reads your consultation the same day, not an automated system.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions